首页> Therapeutic advances in cardiovascular disease> Mechanisms and management of prothrombotic state in COVID-19 disease.

Mechanisms and management of prothrombotic state in COVID-19 disease.

导出 OA

翻译打印收藏纠错

第一作者： Trishna,Acherjee

第一单位： Internal Medicine, BronxCare Health System, Bronx, NY-10457, USA.

作者： Trishna,Acherjee ^[1] ; Aparna,Behara ^[2] ; Muhammad,Saad ^[2] ; Timothy J,Vittorio ^[3]

作者单位： Internal Medicine, BronxCare Health System, Bronx, NY-10457, USA. ^[1] Internal Medicine, BronxCare Health System, Bronx, NY, USA. ^[2] Department of Cardiology, BronxCare Health System, Bronx, NY, USA. ^[3]

关键词 COVID-19 anticoagulation of choice cardiovascular complications prothrombotic state

医学主题词出院后医疗(Aftercare);内皮细胞(Endothelial Cells);人类(Humans);病人出院(Patient Discharge);美国(United States)

DOI 10.1177/17539447211053470

PMID 34693818

发布时间 2022-02-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Therapeutic advances in cardiovascular disease

17539447211053470页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Therapeutic advances in cardiovascular disease

17539447211053470页

检索历史清除

Mechanisms and management of prothrombotic state in COVID-19 disease.

Therapeutic advances in cardiovascular disease

相似文献

同项目论文

Therapeutic advances in cardiovascular disease

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Mechanisms and management of prothrombotic state in COVID-19 disease.

Therapeutic advances in cardiovascular disease

相似文献

同项目论文

Therapeutic advances in cardiovascular disease

相关期刊

检索历史清除